Profile
ENTO VRTX REGN VRNA ARGX ALNY
Company Name Entero Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $13.58M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Jason David Sawyer Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ENTO VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
ENTO VRTX REGN VRNA ARGX ALNY
Last Close $3.79 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $5.63 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.34 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -32.68 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 1014.71 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ENTO VRTX REGN VRNA ARGX ALNY
1 Month Return -23.59 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 75.46 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 793.24 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 657.85 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 509.32 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 828.92 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ENTO VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -3.3 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) -3.68 % - 8.22 % - - -
Growth
ENTO VRTX REGN VRNA ARGX ALNY
Asset Growth 1140.84 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 100 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth 99.9 % 9.09 % -131.37 % 24.59 %
Net Income Growth -14.34 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 99.99 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 99.99 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 99.96 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 99.9 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 25.53 % - -143.33 % -107.98 %
Operating 3 Year CFG 99.99 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 92.46 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 54.46 % -100 % 40.15 % 97.08 %
EPS Growth 91.74 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 88.8 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 15.97 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share 100.34 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -99.86 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -99.89 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -83 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 28.42 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ENTO VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 50 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -11.56 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -24.65 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -3.53 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 413.12 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 105.26 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -3757.18 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -227.47 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 2.55 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.01 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 348.03 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 0.07 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -1.15 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -1.15 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 152.31 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -1984.5 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -227.47 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -5.15 36.72 20 -995.27 128.45 195.85
Price To Operating Cash Flows Ratio TTM -2.53 32.86 16.23 -126.33 145.01 162.25
Price Cash Flow Ratio TTM -2.53 32.86 16.23 -126.33 145.01 162.25
Income Statement (TTM)
ENTO VRTX REGN VRNA ARGX ALNY
Revenue $0B
Gross Profit $0B
Gross Profit Ratio 0%
EBITDA $0B
Net Income $-0.02B
EPS Diluted -5.26
Balance Sheet (MRQ)
ENTO VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B
Total Liabilities $0.03B
Total Equity $0.06B
Total Investments $0B
Total Debt $0B
Total Assets $0.09B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.52
AARD Aardvark Therapeutics, Inc. Common Stock 12.65
ABCL AbCellera Biologics Inc. 3.16
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.13
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.4
ABPWW 0.0155
ABSI Absci Corporation 2.695
ABUS Arbutus Biopharma Corporation 3.84
ABVC ABVC BioPharma, Inc. 1.74
ABVX Abivax SA American Depositary Shares 117.67
ACAD ACADIA Pharmaceuticals Inc. 23.56
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.03
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.25
ACIU AC Immune SA 3.14
ETFs With Exposure to ENTO
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00003 217.96
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00003 165.43
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00003 165.44
VEMPX Vanguard Extended Market Index InstlPlus 0.00003 408.25
Unlock